Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Tim Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →
The 60-second version
Let’s start with the honest part most articles bury: there is no direct head-to-head trial of magnesium glycinate versus citrate for sleep, anxiety, cramps or constipation. So anyone selling you a clear winner is reading marketing, not data. What we can say: both are organic magnesium salts that absorb better than the cheap oxide that fills most supplement shelves. Citrate has a mild osmotic, stool-loosening effect — handy if you’re constipated, annoying if you’re not. Glycinate (bisglycinate) is gentler on the gut and is the usual pick for sleep, anxiety and night-time cramps — chosen for tolerance and the calming amino acid glycine, not because trials prove it beats citrate. The real decision is goal and tolerance, not a bioavailability contest.
First, the honest caveat
Search hard enough and you’ll find confident rankings of magnesium forms. Search the actual literature and you’ll find something different: bioavailability studies comparing organic forms to oxide, outcome trials that used one form or a mix, and a great deal of marketing — but no randomized trial pitting glycinate directly against citrate for the outcomes people actually care about. That absence is the most important fact in this comparison, and any honest guide has to lead with it. What follows is reasoning from mechanism and tolerability, clearly labelled as such.
Both beat oxide — that’s the settled part
The one thing the evidence does establish is that the cheap, common form is the weak one. Magnesium oxide is barely soluble — only about 43% soluble even in simulated stomach acid, versus ~55% for citrate in plain water — and after an oral load, urinary magnesium rose significantly more with citrate than oxide Lindberg 1990. A randomized, double-blind trial likewise found organic forms (citrate and an amino-acid chelate) raised magnesium status more than oxide over 60 days, with citrate producing the highest serum levels Walker 2003.
Glycinate’s absorption data are thinner and come from an unusual population: in patients with surgically shortened bowels, magnesium diglycinate was absorbed about as well as oxide overall, but better in the worst malabsorbers, and was better tolerated — suggesting the glycinate form is absorbed intact, plausibly via a dipeptide route Schuette 1994. That’s a mechanism hint, not proof it out-absorbs citrate. If you want the deeper dive on what the labels actually mean, our bisglycinate label read is blunt about it.
So choose by goal and gut
With absorption roughly a wash between the two organic forms, the sensible tie-breakers are what each form does beyond delivering magnesium:
- Citrate — if you tend toward constipation. Its osmotic effect draws water into the bowel and gently loosens stools. That’s a feature for some and a nuisance for others; at higher doses it can cause loose stools.
- Glycinate — if your gut is sensitive, or your goal is sleep/calm. It’s the gentlest common form, and glycine itself has a mildly calming profile, which is why it’s the default for night-time use and cramps. But be clear-eyed: the magnesium-and-sleep RCT people cite actually used oxide, not glycinate — 500 mg/day improved insomnia measures in older adults Abbasi 2012 — and a systematic review rated the anxiety evidence as suggestive but low-quality Boyle 2017. The sleep case for glycinate specifically rests on tolerance and mechanism, not head-to-head proof.
Glycinate vs citrate, plainly
| Glycinate (bisglycinate) | Citrate | |
|---|---|---|
| Absorption vs oxide | Good (limited direct data) | Good (better-documented) |
| Gut effect | Gentle; least laxative | Mild laxative / loosens stools |
| Usual reason to pick it | Sleep, calm, cramps, sensitive gut | Constipation, general top-up |
| Head-to-head proof | None — no RCT compares the two directly | |
Dose and safety
However you choose, the numbers come from food-and-supplement reference values, not the form. Adults need roughly 400–420 mg/day (men) and 310–320 mg/day (women) from all sources. The Tolerable Upper Intake Level for supplemental magnesium is 350 mg/day — and importantly, that cap applies only to supplements and medications, not to magnesium from food NIH ODS. People with kidney disease should not supplement without medical advice, since impaired kidneys can’t clear excess magnesium. For a fuller breakdown of forms and timing, see our forms-ranked guide.
What the evidence doesn’t show
- No trial shows glycinate beats citrate (or vice versa) for sleep, anxiety, cramps or constipation.
- Glycinate is not proven more absorbable than citrate — both simply beat oxide.
- Magnesium isn’t a cure for insomnia or anxiety; the outcome evidence is modest and mostly used other forms.
Practical takeaways
- Skip oxide if absorption matters — that’s the one claim the data clearly support.
- Constipated? Citrate, and use the gentle laxative effect to your advantage.
- Sleep, calm or a sensitive gut? Glycinate, for tolerance — just know it’s a reasonable bet, not a proven winner.
- Mind the 350 mg supplemental ceiling, and check with a clinician if you have kidney issues.
What magnesium actually does inside you
Before arguing about which salt to swallow, it helps to know why your body wants the mineral at all, because the answer reframes the whole debate. Magnesium is not a single-purpose nutrient. The form your supplement comes in — glycinate, citrate, oxide — is just a delivery vehicle; once the magnesium ion is absorbed and enters your cells, your body uses it the same way no matter what it travelled with. Magnesium is a required cofactor in more than 300 enzyme reactions and is essential to the most basic business of being alive, including energy production and the synthesis of DNA, RNA, fats and proteins Jahnen-Dechent 2012. Crucially, the body’s universal energy currency, ATP, is biologically active only when it is bound to magnesium as Mg-ATP, so every cell that burns energy — every heartbeat, every muscle contraction, every nerve impulse — depends on having enough magnesium on hand Jahnen-Dechent 2012.
The mineral also behaves as a natural calcium counterweight. By acting as a natural calcium antagonist at nerve and muscle membranes, magnesium dampens excitatory signalling, which is the mechanistic reason it is studied for muscle relaxation, blood-pressure regulation and sleep Jahnen-Dechent 2012. There is one wrinkle the glycinate-versus-citrate argument usually skips: the carrier molecule is not always inert. In magnesium glycinate the magnesium is bound to glycine, an amino acid that is itself a calming neurotransmitter in the brain and spinal cord, which gives glycinate a plausible (though not proven in a head-to-head trial) reason to feel soothing beyond the magnesium alone. Citric acid, the carrier in citrate, is simply a Krebs-cycle acid with no comparable nervous-system role. None of this makes one form superior on paper; it just explains why the marketing leans the way it does. What the science still does not show is a clinical trial proving the glycine delivered this way meaningfully changes brain chemistry or outcomes versus citrate — so treat the “calming amino acid” pitch as mechanism, not proof.
Why so many people fall short — and who is most at risk
A fair question before buying any form is whether you need a supplement in the first place. For a large slice of the population the honest answer is “possibly,” because dietary intake is widely subpar. An analysis of United States national survey data found that roughly 48 percent of the population consumed less than the estimated average requirement of magnesium from food, and the same review noted that low intake tracks with conditions such as type 2 diabetes, hypertension and metabolic syndrome — though association is not the same as cause Rosanoff 2012. The recommended daily intake is roughly 400–420 mg for adult men and 310–320 mg for adult women, and the easiest way to close a gap is food first: pumpkin seeds, almonds, spinach, black beans, edamame and whole grains are all dense sources NIH ODS. It is worth noting why intakes have drifted down: refined and processed foods lose most of their magnesium during milling, so a diet heavy in white bread, snacks and soft drinks can be calorie-rich yet magnesium-poor, and the long-running survey data show the share of Americans falling short has stayed close to half across multiple cycles rather than steadily improving Rosanoff 2012.
Certain groups are at higher risk of a genuine shortfall and are worth flagging. Older adults absorb less magnesium from the gut and excrete more in the urine; people with gastrointestinal disorders such as Crohn’s disease or coeliac disease, or who have had bowel surgery, lose magnesium through malabsorption; people with type 2 diabetes waste it in their urine; and people with long-standing heavy alcohol use are commonly depleted NIH ODS. A second, frustrating wrinkle is that a routine blood test is a poor way to confirm a quiet deficiency. Only about one percent of the body’s magnesium sits outside cells, and just a fraction of one percent is in the serum a standard test measures, so blood levels can read “normal” while tissue stores run low Jahnen-Dechent 2012. The practical upshot is not to panic-supplement, but to recognise that if you rarely eat leafy greens, nuts, legumes or whole grains, or you fall into one of the at-risk groups, the real question shifts from “glycinate or citrate” to “am I getting enough at all” — and a clinician can judge that better than a single serum number.
Medications that quietly change the equation
The glycinate-versus-citrate choice matters far less than a drug interaction many supplement shoppers never hear about, and this is where a brief word with a pharmacist or doctor genuinely earns its keep. Two common prescription classes can pull magnesium down. Long-term use of proton-pump inhibitors — the acid-reducing drugs taken for reflux — has been linked to low blood magnesium. A community study of more than 95,000 ambulatory patients found that recent PPI use was associated with markedly higher odds of hypomagnesemia (an adjusted odds ratio of about 1.66 for any low reading and 3.79 for a severe one), a signal strong enough that the United States Food and Drug Administration issued a 2011 safety communication advising magnesium monitoring during prolonged PPI therapy Markovits 2014. Common diuretics (“water pills”) can also increase urinary magnesium loss, and the risk is highest when a diuretic and a PPI are taken together NIH ODS.
The interaction also runs the other way: magnesium can blunt the absorption of certain drugs by binding them in the gut, so timing matters. Tetracycline and quinolone antibiotics and oral bisphosphonates taken for osteoporosis should each be separated from a magnesium supplement by at least two hours, and the antibiotics often need a wider gap — taken either at least two hours before or four to six hours after the magnesium NIH ODS. Levothyroxine for the thyroid needs an even larger buffer: it should be separated from a magnesium supplement by at least four hours, because magnesium can reduce how much of the thyroid hormone is absorbed Drugs.com. This is squarely a “talk to your clinician or pharmacist” situation — especially if you take any of these medicines, are pregnant, have kidney disease, or are choosing a supplement for an older adult or a child — because the interaction, not the salt form, is what actually moves the needle on your health. People with reduced kidney function in particular should not start magnesium supplements without medical guidance, since impaired kidneys clear excess magnesium poorly.
The other forms — and the marketing claims worth ignoring
Glycinate and citrate are not the only options on the shelf, and the newer arrivals come wrapped in bigger promises that deserve a sceptical read. Magnesium L-threonate is sold for “brain” benefits on the strength of animal work suggesting it raises magnesium inside the brain better than other forms. The human evidence is early and thin: a six-week randomised, placebo-controlled trial in 100 healthy adults aged 18 to 45 reported a modest edge over placebo on a composite cognition score and on sleep-related impairment, but the study was funded by the ingredient’s manufacturer, which designed it and supplied its product — a real conflict of interest that should temper any “reverses brain aging” headline Lopresti 2025. Treat threonate as promising-but-unproven, not established, and note it is also one of the priciest forms per dose. A further honest caveat: that trial enrolled healthy young adults, so even taken at face value it says little about whether the form helps the older adults most worried about memory, and an independent, manufacturer-neutral replication has not yet been published Lopresti 2025.
Magnesium malate, marketed for “energy” and fibromyalgia because malic acid is a Krebs-cycle intermediate, has essentially no rigorous human trials supporting those specific claims; it is a perfectly reasonable, well-absorbed organic salt, but the energy story is marketing rather than data. The clearest case to dismiss outright is topical magnesium — the sprays, oils and flake “foot soaks” sold to bypass the gut. A peer-reviewed review of the literature concluded that meaningful absorption of magnesium through intact skin is scientifically unsupported, with laboratory flux studies showing that transdermal passage is minimal Gröber 2017. Magnesium-rich bathing may soothe skin locally, but it is not a reliable way to raise the magnesium in your body Gröber 2017. If your goal is simply to correct a shortfall, an inexpensive organic salt — glycinate if your gut is sensitive, citrate if you also want gentle help with constipation — taken consistently with food and split into smaller doses remains the evidence-based choice over any premium form promising organ-specific magic.
References
Walker 2003Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003;16(3):183-191. View source →Lindberg 1990Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990;9(1):48-55. View source →Schuette 1994Schuette SA, Lashner BA, Janghorbani M. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr. 1994;18(5):430-435. View source →Abbasi 2012Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169. (Note: used magnesium oxide.) View source →Boyle 2017Boyle NB, Lawton C, Dye L. The effects of magnesium supplementation on subjective anxiety and stress—a systematic review. Nutrients. 2017;9(5):429. (Evidence rated low-quality.) View source →NIH ODSNational Institutes of Health, Office of Dietary Supplements. Magnesium — Fact Sheet for Health Professionals. RDA 400-420 mg/day (men), 310-320 mg/day (women); supplemental UL 350 mg/day. View source →Jahnen-Dechent 2012Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3-i14. doi:10.1093/ndtplus/sfr163. PMC4455825. View source →Rosanoff 2012Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev. 2012;70(3):153-164. doi:10.1111/j.1753-4887.2011.00465.x. PMID: 22364157. View source →Markovits 2014Markovits N, Kurnik D, Halkin H, et al. The association of proton pump inhibitors and hypomagnesemia in the community setting. J Clin Pharmacol. 2014;54(8):889-895. doi:10.1002/jcph.316. PMID: 24771616. View source →Lopresti 2025Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Front Nutr. 2025;12:1729164. doi:10.3389/fnut.2025.1729164. (Manufacturer-funded.) View source →Gröber 2017Gröber U, Werner T, Vormann J, Kisters K. Myth or reality—transdermal magnesium? Nutrients. 2017;9(8):813. doi:10.3390/nu9080813. PMC5579607. View source →Drugs.comDrugs.com. Levothyroxine and magnesium citrate drug interactions. View source →



